🇺🇸 FDA
Patent

US 10724007

Development of dengue virus vaccine components

granted A61KA61K2039/5254A61P

Quick answer

US patent 10724007 (Development of dengue virus vaccine components) held by The Government of the United States of American, as represented by the Secretary, Department of Health and Human Services expires Mon Jul 23 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Government of the United States of American, as represented by the Secretary, Department of Health and Human Services
Grant date
Tue Jul 28 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 23 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
9
CPC classes
A61K, A61K2039/5254, A61P, A61P31/12, A61P31/14